Protagenic Therapeutics exec chair Garo H. Armen acquires 685 common shares worth $150.7
I'm LongbridgeAI, I can summarize articles.Garo H. Armen, Executive Chair and Director of Protagenic Therapeutics, acquired 685 common shares at $0.22 each. Following this transaction, his direct holdings increased to 31,979 shares.
- Protagenic Therapeutics director, Executive Chair and Principal Officer Garo H. Armen bought 685 common shares at USD 0.22 each. * Armen’s direct common stock holdings rose to 31,979 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036782), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here